Compare UK prices. 40+ products · 22 retailers scored
PeptideClear UK

Editorial · Wellness · IV therapy

IV drip vs oral supplement: when each makes sense

OM

Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)

Published Tue Jun 02 2026 01:00:00 GMT+0100 (British Summer Time) · 6 min read

An IV drip delivers nutrients straight into the bloodstream, bypassing the gut; an oral supplement is cheaper, slower and subject to digestive absorption. The bioavailability argument for IV is real for a few poorly absorbed compounds but is overstated for most water-soluble vitamins, where a healthy gut absorbs what the body needs and excretes surplus from both routes. For most healthy, non-deficient adults, diet meets nutrient needs and neither route is necessary. Where a genuine deficiency exists, that is a GP matter, not a wellness purchase. The evidence for wellness IV drips in healthy adults is limited.

The single argument the IV industry leans on hardest is bioavailability: a drip bypasses your gut, a capsule does not. This post takes that claim seriously and works out where it holds and where it does not, comparing the two routes on absorption, cost, evidence and convenience. It is editorial commentary. We do not sell drips or supplements, and we do not recommend a route for any individual.

The bioavailability argument, examined

The mechanism is true as far as it goes. An IV infusion places nutrients directly in the bloodstream at close to one hundred per cent availability, while an oral dose has to survive stomach acid and be absorbed across the gut wall, so some is lost. For a handful of compounds that are genuinely poorly absorbed orally, such as glutathione, that difference is real and is the honest part of the IV case.

But for most of what goes into a wellness drip, water-soluble B vitamins and vitamin C, a healthy gut already absorbs what the body needs from a normal diet or a cheap oral dose. Beyond the body’s requirement, the surplus is excreted whether it arrived by vein or by mouth. So higher blood availability does not translate into a benefit once you are already getting enough. The bioavailability argument is strongest exactly where it is least often made, and weakest where the marketing leans on it hardest.

Cost and convenience

The cost gap is enormous. An oral supplement is a few pounds a month; an IV drip is £75 to £150 or far more per session, with NAD+ running into four figures across a course. On pure cost per nutrient delivered, oral wins by orders of magnitude.

Convenience runs the other way for some people. A drip is a single supervised session, sometimes with a relaxing hour in a chair or an at-home visit, whereas a supplement is a daily habit that is easy to forget. Part of what a drip sells is the event and the rest, not just the nutrients, and it is fair to value that, as long as it is not mistaken for a clinical edge.

What the evidence supports

For healthy, non-deficient adults, the high-quality evidence that either route improves wellbeing is limited, and it is no stronger for IV than for oral. Most people in the UK meet their nutrient needs through diet, and supplementation, by any route, mainly helps when there is a genuine shortfall. The drip does not unlock an outcome the capsule cannot reach in this population; it mostly delivers the same surplus faster and far more expensively.

When a clinical route matters instead

There is a real category where intravenous delivery is the right answer, and it is not the wellness one. Documented deficiencies, malabsorption conditions, and certain medical situations are treated with intravenous nutrients under medical supervision, on an NHS or private hospital pathway with diagnosis and monitoring. If you suspect a true deficiency, the correct step is a blood test and a conversation with your GP, not a self-selected wellness drip or a self-selected supplement aisle.

The honest summary

For most healthy adults, the comparison resolves to: diet first, a cheap oral supplement if there is a specific reason, and an IV drip only if you are buying the convenience and experience with eyes open about the thin evidence. The bioavailability headline is real for a few compounds and oversold for most. Speak to your GP for anything that feels like a genuine health problem.

See best IV drip UK for matching category to goal, IV drip UK for the category overview, and the IV therapy hub for the full landscape.

PeptideClear is editorial commentary, not clinical advice. We do not sell, prescribe, or recommend a specific supplement, dose, or clinic for a specific person. NAD+, NMN and NR are sold in the UK as food supplements. Decisions about supplements or private clinical services are between you and a suitably qualified healthcare professional.

Read our full methodology and how we are funded.

Reviewed by Oliver Mackman, editorial director · last reviewed Tue Jun 02 2026 01:00:00 GMT+0100 (British Summer Time)
Trust, Legal and Governance

PeptideClear is a trading name of Best Business Loans Ltd, registered in England and Wales (company number 16833937). All services, operations and publications under the PeptideClear brand are delivered by Best Business Loans Ltd.

Legal and Registration

Registered in England and Wales. Company number 16833937. D‑U‑N‑S 234324824. ICO registered, reference ZC151816 (certificate, verify). Registered supplier on the UK Government's Find a Tender Service (FTS). Details publicly available via Companies House and OpenCorporates.

Standards and Governance

Operates under UK data protection and consumer standards. Aligns with UK GDPR, ISO 27001 and ISO 9001 principles. Working towards Cyber Essentials certification.

Domain Continuity

Primary domain peptideclear.co.uk. Business ownership, entity and services remain unchanged. Reviewed quarterly.